UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014405
Receipt number R000016748
Scientific Title Argatroban, aspirin and clopidgrel combination therapy for non-cardioembolic acute ischemic stroke -a prospective, randomized, argatroban and aspirin-controlled study-
Date of disclosure of the study information 2014/06/27
Last modified on 2016/02/01 19:09:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Argatroban, aspirin and clopidgrel combination therapy for non-cardioembolic acute ischemic stroke -a prospective, randomized, argatroban and aspirin-controlled study-

Acronym

Dual antiplatelet therapy for non-cardioembolic acute ischemic stroke

Scientific Title

Argatroban, aspirin and clopidgrel combination therapy for non-cardioembolic acute ischemic stroke -a prospective, randomized, argatroban and aspirin-controlled study-

Scientific Title:Acronym

Dual antiplatelet therapy for non-cardioembolic acute ischemic stroke

Region

Japan


Condition

Condition

Acute non-cardioembolic stroke

Classification by specialty

Neurology Emergency medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Efficacy and safety of combination therapy (argatoroban, aspirin and clopidgrel)

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. NIHSS score at 7 days after admission and at day of discharge
2. modified Rankin scale score at 3 months after stroke

Key secondary outcomes

1. outcome at hospital discharge
2. TIA, stroke recurrence, intracranial hemorrhage, cardiovascular event within 3 months after stroke


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Dual antiplatelet group:
argatoroban, aspirin 100mg (day1 200mg), cropidogrel 75mg(day1 300mg) for 7 days, after day 7 mono antiplatelet agent

Interventions/Control_2

Mono antiplatelet group:
argatroban, aspirin 100mg (day1 200mg) for 7 days, after day 7 mono antiplatelet agent

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. non-cardioembolic stroke within 48 hours of onset
2. small vessel disease (lacunar or BAD (branch atheromatous disease))
3. NIHSS score below 20 points on admission
4. mRS score 0-2 before onset
5. patients written informed consent

Key exclusion criteria

1. cardioembolic stroke
2. antithrombotic therapy (cilostazol, ticlopidine, aspirin 100mg over, clopidogrel 75mg over, anticoagulants) before onset
3. congestive heart failure
4. medical history of allergies of argatroban, aspirin, clopidogrel
5. blood pressure cannot be controlled below 180/105mmHg
6. high hemorrhagic risk
7. severe stenosis of major cerebral and cervical artery
8. patients who are not appropriate to participate in this trial

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ryoji Nishi

Organization

Okazaki City Hospital

Division name

Department of Neurology

Zip code


Address

1-3 Gosyoai Kouryuji-cho Okazaki, Aichi

TEL

0564-21-8111

Email

nishi-r@gc4.so-net.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ryoji Nishi

Organization

Okazaki City Hospital

Division name

Department of Neurology

Zip code


Address

1-3 Gosyoai Kouryuji-cho Okazaki, Aichi

TEL

0564-21-8111

Homepage URL


Email

nishi-r@gc4.so-net.ne.jp


Sponsor or person

Institute

Department of Neurology Okazaki City Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岡崎市民病院(愛知県)


Other administrative information

Date of disclosure of the study information

2014 Year 06 Month 27 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 11 Month 18 Day

Date of IRB


Anticipated trial start date

2013 Year 12 Month 01 Day

Last follow-up date

2014 Year 12 Month 19 Day

Date of closure to data entry

2015 Year 01 Month 31 Day

Date trial data considered complete

2015 Year 03 Month 31 Day

Date analysis concluded

2015 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2014 Year 06 Month 27 Day

Last modified on

2016 Year 02 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016748


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name